Phase 1 Study of Epetraborole Tablets

Clinical trial NCT04892641 · COMPLETED

Trial details

NCT number: NCT04892641
Sponsor: AN2 Therapeutics, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-06-10
Primary completion: 2022-02-26
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.